We provide you with 20 years of free, institutional-grade data for NVTA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NVTA. Explore the full financial landscape of NVTA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about NVTA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Invitae Corporation(NYSE:NVTA) 
Invitae Corporation, a medical genetics company, integrates genetic information into healthcare decision-making by clinicians and patients in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology...
Website: http://www.invitae.com
Founded: 2010
Full Time Employees: 1,900
CEO / Co-Founder: Sean George
Sector: Healthcare
Industry: Diagnostics & Research